Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents
Comparative Effectiveness Research · 2015
DOI: 10.2147/cer.s62090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Effectiveness Research, 2015. Verfasst von Nicole Meyer und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Meyer, N., Hao, Y., Landsman-Blumberg, P., Johnson, W., Juneau, P., & Rogerio, J. W. (2015). Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents. Comparative Effectiveness Research. https://doi.org/10.2147/cer.s62090
Vancouver
Meyer N, Hao Y, Landsman-Blumberg P, Johnson W, Juneau P, Rogerio JW. Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents. Comparative Effectiveness Research. 2015. doi:10.2147/cer.s62090
BibTeX
@article{Meyer2015,
author = {Meyer, Nicole and Hao, Yanni and Landsman-Blumberg, Pamela and Johnson, William and Juneau, Paul and Rogerio, Jaqueline Willemann},
title = {Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents},
journal = {Comparative Effectiveness Research},
year = {2015},
doi = {10.2147/cer.s62090}
}
EUVIMED